Bouygues SA
Bouygues SA (EN.PA) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Bouygues SA (EN.PA), featuring income statements, balance sheets, and cash flow data.
Bouygues SA (EN.PA) Income Statement & Financial Overview
Analyze Bouygues SA’s EN.PA earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $12.59B | $15.28B | $14.98B | $14.21B |
| Cost of Revenue | $5.41B | $6.65B | $6.87B | $6.26B |
| Gross Profit | $7.18B | $8.62B | $8.11B | $7.96B |
| Gross Profit Ratio | $0.57 | $0.56 | $0.54 | $0.56 |
| R&D Expenses | $0.00 | $76.00M | $0.00 | $0.00 |
| SG&A Expenses | $178.00M | $285.00M | $218.00M | $0.00 |
| Operating Expenses | $7.16B | $7.86B | $7.23B | $7.32B |
| Total Costs & Expenses | $12.57B | $14.51B | $14.10B | $13.58B |
| Interest Income | $46.00M | $47.00M | $30.00M | $42.00M |
| Interest Expense | $157.00M | $118.00M | $154.00M | $186.00M |
| Depreciation & Amortization | $711.00M | $649.00M | $578.00M | $705.00M |
| EBITDA | $750.00M | $1.32B | $1.46B | $1.37B |
| EBITDA Ratio | $0.06 | $0.09 | $0.10 | $0.10 |
| Operating Income | $21.00M | $768.00M | $878.00M | $635.00M |
| Operating Income Ratio | $0.002 | $0.05 | $0.06 | $0.04 |
| Other Income/Expenses (Net) | -$106.00M | -$105.00M | -$103.00M | -$101.00M |
| Income Before Tax | -$85.00M | $663.00M | $775.00M | $534.00M |
| Income Before Tax Ratio | -$0.007 | $0.04 | $0.05 | $0.04 |
| Income Tax Expense | $63.00M | $225.00M | $230.00M | $155.00M |
| Net Income | -$156.00M | $371.00M | $501.00M | $332.00M |
| Net Income Ratio | -$0.01 | $0.02 | $0.03 | $0.02 |
| EPS | -$0.41 | $0.98 | $1.33 | $0.88 |
| Diluted EPS | -$0.41 | $0.98 | $1.33 | $0.88 |
| Weighted Avg Shares Outstanding | $380.49M | $378.57M | $376.69M | $377.27M |
| Weighted Avg Shares Outstanding (Diluted) | $380.49M | $378.57M | $376.69M | $377.27M |
The company's financials show resilient growth, with revenue advancing from $14.21B in Q2 2024 to $12.59B in Q1 2025. Gross profit remained healthy with margins at 57% in Q1 2025 compared to 56% in Q2 2024. Operating income hit $21.00M last quarter, sustaining a consistent 0% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $750.00M. Net income dropped to -$156.00M, while earnings per share reached -$0.41. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan